Company / Book Value per Share
Haemonetics Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$16.162
FY2025
5-year range
$14.248 / $19.028
FY2021-FY2025
Trend
-15.1%
vs FY2024
Sector context
#77 of 163
Health Care
What the data says
At $16.162, Haemonetics's book value per share ranks #77 of 163 in the Health Care sector. Book Value per Share has fluctuated over the past 10 years, ranging from $11.446 in FY2020 to $19.028 in FY2024.
Based on SEC 10-K filings.
$16.162 in FY2025 with a 5-year CAGR of +7.1%.
Remained stable around $16.162 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +3.5%
- 5-Year CAGR
- +7.1%
- 10-Year CAGR
- -
Sector benchmark
#77 of 163 in Health CareTop 47% of 163This company $16.162 Sector average $47.415
▼
-65.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.1%, indicating consistent growth.
- In FY2025, book value per share decreased 15.1% year-over-year.
- Ranks #77 out of 163 companies in the Health Care sector.
- Peak book value per share was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.162 | -15.1% |
| FY2024 | $19.028 | +19.6% |
| FY2023 | $15.915 | +9.2% |
| FY2022 | $14.575 | +2.3% |
| FY2021 | $14.248 | +24.5% |
| FY2020 | $11.446 | -11.2% |
| FY2019 | $12.889 | -10.5% |
| FY2018 | $14.399 | -0.8% |
| FY2017 | $14.521 | +4.0% |
| FY2016 | $13.965 | -12.0% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026